Real-time enrollment status for this invasive fungal infection clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:37 PM UTC
| NCT Number | NCT04665037 |
| Recruiting Status | Recruiting |
| Condition | Invasive Fungal Infection |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 12, 2026 (Aug 12, 2026) |
As of October 12, 2026: Clinical trial NCT04665037 is currently recruiting participants. This phase2 study for invasive fungal infection is actively seeking new participants at 5 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04665037 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04665037 was last updated Aug 12, 2026 (August 12, 2026). HelloStudys verifies this status automatically.